Trial Outcomes & Findings for Comparison of Dexamethasone Oral Preparations to Assess Taste and Acceptance in Children With Asthma and Croup (NCT NCT03705273)
NCT ID: NCT03705273
Last Updated: 2021-11-08
Results Overview
Presence of nausea after medication administration (yes/no) measured by participant self-report
TERMINATED
PHASE4
40 participants
1 hour
2021-11-08
Participant Flow
Forty participants were enrolled and randomized, of which 20 were randomized to receive dexamethasone tablets.
Participant milestones
| Measure |
Dexamethasone Tablets
Dexamethasone tablets crushed and administered in apple sauce or pudding at a dose of 0.6 mg/kg
|
Dexamethasone-IV Solution-in-syrup
Dexamethasone-IV solution-in-syrup at a dose of 0.6 mg/kg
|
|---|---|---|
|
Overall Study
STARTED
|
20
|
20
|
|
Overall Study
COMPLETED
|
20
|
20
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Comparison of Dexamethasone Oral Preparations to Assess Taste and Acceptance in Children With Asthma and Croup
Baseline characteristics by cohort
| Measure |
Dexamethasone IV for PO
n=20 Participants
Dexamethasone IV for PO solution mixed with sugar syrup to be given orally
Dexamethasone IV for PO: Common pediatric emergency department practice
|
Dexamethasone Crushed Tablets
n=20 Participants
Dexamethasone tablet crushed and placed in apple sauce or pudding to be given orally or dexamethasone IV solution in cherry syrup
|
Total
n=40 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Diagnosis asthma
|
15 Participants
n=5 Participants
|
16 Participants
n=7 Participants
|
31 Participants
n=5 Participants
|
|
Diagnosis croup
|
5 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
9 Participants
n=5 Participants
|
|
Age, Continuous
|
2.75 years
STANDARD_DEVIATION 1.88 • n=5 Participants
|
2.70 years
STANDARD_DEVIATION 1.92 • n=7 Participants
|
2.75 years
STANDARD_DEVIATION 1.88 • n=5 Participants
|
|
Sex: Female, Male
Female
|
7 Participants
n=5 Participants
|
12 Participants
n=7 Participants
|
19 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
13 Participants
n=5 Participants
|
8 Participants
n=7 Participants
|
21 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
15 Participants
n=5 Participants
|
15 Participants
n=7 Participants
|
30 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
5 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
10 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
20 participants
n=5 Participants
|
20 participants
n=7 Participants
|
40 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 1 hourPresence of nausea after medication administration (yes/no) measured by participant self-report
Outcome measures
| Measure |
Dexamethasone Tablets
n=20 Participants
Dexamethasone tablets crushed and mixed in apple sauce
|
Dexamethasone IV for PO
n=20 Participants
Dexamethasone IV solution mixed with cherry syrup
|
|---|---|---|
|
Number of Participants With Nausea
|
3 Participants
|
0 Participants
|
SECONDARY outcome
Timeframe: 1 hourReason for patient needing a second dose of dexamethasone; such as spit dose up or vomiting dose
Outcome measures
| Measure |
Dexamethasone Tablets
n=20 Participants
Dexamethasone tablets crushed and mixed in apple sauce
|
Dexamethasone IV for PO
n=20 Participants
Dexamethasone IV solution mixed with cherry syrup
|
|---|---|---|
|
Number of Participants Requiring Second Dose of Dexamethasone
|
0 Participants
|
0 Participants
|
Adverse Events
Dexamethasone IV for PO
Dexamethasone Crushed Tablets
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Donald H. Arnold, MD, MPH
Vanderbilt University School of Medicine
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place